S3834-2011 Actions

• Aug 17, 2011: SIGNED CHAP.467
• Aug 5, 2011: DELIVERED TO GOVERNOR
• Jun 17, 2011: returned to senate
• Jun 17, 2011: passed assembly
• Jun 17, 2011: ordered to third reading rules cal.248
• Jun 17, 2011: substituted for a7156a
• Jun 16, 2011: referred to ways and means
• Jun 16, 2011: DELIVERED TO ASSEMBLY
• Jun 16, 2011: PASSED SENATE
• Jun 13, 2011: AMENDED ON THIRD READING 3834A
• Jun 1, 2011: ADVANCED TO THIRD READING
• May 25, 2011: 2ND REPORT CAL.
• May 24, 2011: 1ST REPORT CAL.855
• Apr 5, 2011: REPORTED AND COMMITTED TO FINANCE
• Mar 7, 2011: REFERRED TO CORPORATIONS, AUTHORITIES AND COMMISSIONS

S3834-2011 Meetings

S3834-2011 Calendars

S3834-2011 Votes

S3834-2011 Memo

BILL NUMBER:S3834

TITLE OF BILL:
An act
to amend the New York state urban development corporation act, in
relation to the economic development fund

PURPOSE:
This bill would create new purposes for the economic development fund to
help fund Biosciences curriculum development and workforce training, as
well as facility improvement in accordance with federal regulations.

SUMMARY OF PROVISIONS:
This bill would amend Subdivision 1 of section 16-m of chapter 174 of
the laws of 1968, constituting the New York state urban development
corporation act, by adding new paragraphs to provide funds to
biosciences research institutions and organizations on a competitive
basis to develop curriculum and administer bioscience specific training
programs for current and prospective industry employees. The bill would
also provide assistance to businesses that conduct basic, applied or
translational research that leads to the development of products that
improve human health or agriculture and that require approval by the
federal food and drug administration based on compliance with federal
Good Manufacturing Practice Regulations.

JUSTIFICATION:
Bioscience-based industries such as those manufacturing medical devices
hold an important place in clusters of the knowledge- based economy in
New York State. In roundtable discussions hosted by the Task Force on
University-Industry Cooperation and the Commission on Science and
Technology, participants called for new legislative initiatives that
benefit the biosciences industry. It was noted that the biosciences are
and are likely to continue to be very important in New York State, and
that New York continues to be a leader in attracting research for
biosciences research.

LEGISLATIVE HISTORY:
2009-10: S.1147; 2007-08: S.7840

FISCAL IMPLICATIONS:
None.

EFFECTIVE DATE:
Immediately, with provisions.

S3834-2011 Text

 S T A T E   O F   N E W   Y O R K
 
 
                                         3834
 2011-2012 Regular Sessions
 I N  SENATE
 March 7, 2011
 
 Introduced  by  Sen. LAVALLE -- read twice and ordered printed, and when
 printed to be committed to the Committee on Corporations,  Authorities
 and Commissions
 

AN ACT to amend the New York state urban development corporation act, in
 relation to the economic development fund
 

THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM
 BLY, DO ENACT AS FOLLOWS:

 

Section 1. Paragraph (k) of subdivision 1 of section 16-m of section 1
 of chapter 174 of the laws of 1968,  constituting  the  New  York  state
 urban  development  corporation act, as added by section 4 of part FF of
 chapter 59 of the laws of 2006, is amended and two  new  paragraphs  (1)
 and (m) are added to read as follows:

 (k)  Assistance  for  regional  partnership  proposals, as provided in
 subdivision 12 of section 3154 of the public authorities law[.];
 (1) ASSISTANCE TO BIOSCIENCES RESEARCH INSTITUTIONS AND  ORGANIZATIONS
 ON  A  COMPETITIVE BASIS TO DEVELOP CURRICULUM AND ADMINISTER BIOSCIENCE
 SPECIFIC TRAINING PROGRAMS FOR CURRENT AND PROSPECTIVE INDUSTRY  EMPLOY
 EES,  IN  CONSULTATION  WITH  THE NEW YORK STATE FOUNDATION FOR SCIENCE,
 TECHNOLOGY AND INNOVATION ESTABLISHED PURSUANT TO ARTICLE  10-A  OF  THE
 PUBLIC  AUTHORITIES  LAW.  FOR  THE PURPOSES OF THIS PARAGRAPH, THE TERM
 BIOSCIENCES RESEARCH SHALL INCLUDE, BUT NOT BE LIMITED  TO,  THE  BASIC,
 APPLIED,  OR  TRANSLATIONAL  RESEARCH  THAT  LEADS TO THE DEVELOPMENT OF
 THERAPEUTICS, DIAGNOSTICS, OR DEVICES, TO IMPROVE HUMAN HEALTH OR  AGRI
 CULTURE AND THAT REQUIRE FEDERAL DRUG ADMINISTRATION APPROVAL;
 (M)  ASSISTANCE  TO BUSINESSES THAT CONDUCT BASIC, APPLIED OR TRANSLA
 TIONAL RESEARCH THAT LEADS TO THE DEVELOPMENT OF PRODUCTS  THAT  IMPROVE
 HUMAN  HEALTH  OR  AGRICULTURE  AND THAT REQUIRE APPROVAL BY THE FEDERAL
 FOOD AND DRUG ADMINISTRATION, IN ORDER TO CREATE OR  EXPAND  FACILITIES,
 IN  ACCORDANCE  WITH  GOOD MANUFACTURING PRACTICE REGULATIONS, THAT WILL
 CREATE OR RETAIN MORE THAN FIFTY JOBS. FOR PURPOSES OF  THIS  PARAGRAPH,
 GOOD  MANUFACTURING  PRACTICE  REGULATIONS  REFERS  TO THOSE REGULATIONS
 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD09916-01-1
 
       S. 3834                             2
 PROMULGATED BY THE UNITED STATES FOOD AND DRUG ADMINISTRATION UNDER  THE
 AUTHORITY OF THE FEDERAL FOOD, DRUG AND COSMETIC ACT.
 

S  2.  This act shall take effect immediately; provided, however, that
 the amendments to section 16-m of the urban development corporation  act
 made  by  section  one  of  this act shall not affect the repeal of such
 section and shall be deemed repealed therewith.

*By contributing or voting you agree to the Terms of Participation and Privacy Policy and verify you are over 13.

Discuss!